Cite This Item

Copy Citation

MLA
Owens, Douglas K., et al. “Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use.” Quantitative Evaluation of HIV Prevention Programs, edited by Edward H. Kaplan and Ron Brookmeyer, Yale University Press, New Haven; London, 2002, pp. 143–172, www.jstor.org/stable/j.ctt1npfnr.11. Accessed 25 May 2020.
APA
Owens, D., Edwards, D., & Shachter, R. (2002). Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use. In Kaplan E. & Brookmeyer R. (Eds.), Quantitative Evaluation of HIV Prevention Programs (pp. 143-172). New Haven; London: Yale University Press. Retrieved May 25, 2020, from www.jstor.org/stable/j.ctt1npfnr.11
CHICAGO
Owens, Douglas K., Donna M. Edwards, and Ross D. Shachter. "Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use." In Quantitative Evaluation of HIV Prevention Programs, edited by Kaplan Edward H. and Brookmeyer Ron, 143-72. New Haven; London: Yale University Press, 2002. Accessed May 25, 2020. www.jstor.org/stable/j.ctt1npfnr.11.

Export Citation

Export a RIS file (For EndNote, ProCite, Reference Manager, Zotero, Mendeley…)
Export a Text file (For BibTex)
Note: Always review your references and make any necessary corrections before using. Pay attention to names, capitalization, and dates.